Leflunomide Tablet
Product Images NDC 23155-044

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Leflunomide (NDC 23155-044). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cfa52b95 F6ee 4a2c A320 E190f716d33b 01

FDA Label Image

Cfa52b95 F6ee 4a2c A320 E190f716d33b 02

This appears to be a pharmaceutical product with the name A77 1726 and the active ingredient is teriflunomide. No additional information is available.*

FDA Label Image

Cfa52b95 F6ee 4a2c A320 E190f716d33b 03

FDA Label Image

Cfa52b95 F6ee 4a2c A320 E190f716d33b 04

FDA Label Image

Cfa52b95 F6ee 4a2c A320 E190f716d33b 05

FDA Label Image

Cfa52b95 F6ee 4a2c A320 E190f716d33b 06

This appears to be a table showing a change in functional ability measure with different medications. The table includes four medications: Loflunomide, Methotrexate, Placebo, and Sulfasalazine. The measure of improvement is in pounds (£) and is presumably a monetary value associated with the improvement. However, without more context, it is difficult to determine the exact meaning behind these values.*

FDA Label Image

Cfa52b95 F6ee 4a2c A320 E190f716d33b 07

FDA Label Image

Cfa52b95 F6ee 4a2c A320 E190f716d33b 08

The description of the text is "NDC 23155-043-03 Leflunomide Tablets, USP".*

FDA Label Image

Cfa52b95 F6ee 4a2c A320 E190f716d33b 09

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.